Part 2 of a series on reflux, acid, and whole-body health. Part 1 ended on a loose thread worth pulling: long-term acid suppression can feed bacterial overgrowth and a disrupted gut. That disruption doesn’t stay in the gut. It reaches the lungs through what researchers call the gut-lung axis. Here’s where that thread leads.
If you’re living with a chronic breathing condition, asthma, COPD, sarcoidosis, pulmonary fibrosis, or a cough that won’t quit, there’s a good chance reflux is riding along with it.[2, 12] In our work with lung patients, that pairing is almost the rule, not the exception. Acid reflux and lung disease showing up together isn’t a coincidence. There are actually two roads connecting the gut to the lungs here, and long-term acid suppression can pave both while fixing neither.[12]
Two Roads From Gut to Lung
Part 1 followed one of them to the end: quiet stomach acid long enough and you can open the gate to bacterial overgrowth (SIBO) and a less diverse, less resilient microbiome. That disrupted gut is in constant conversation with the immune system and with inflammation everywhere, the lungs included, through the gut-lung axis.[3, 12] That’s the slow, systemic road, and researchers are still mapping it. The second road is faster and more mechanical, and it’s the one most people with a breathing condition can already feel.
Acid Reflux and Lung Disease Feed Each Other
The relationship runs both directions. Struggling, over-worked breathing mechanics change the pressures inside your chest and abdomen in ways that pull stomach contents upward. And once that happens, refluxed material (and the airway reflexes it triggers) can irritate already-sensitive lungs.[2, 12] So the lungs make the reflux worse, and the reflux nags the lungs. Neither is really an “acid problem.” Both are mechanical and neurological problems.
Here’s the Part That Surprises People
Because reflux shows up so often alongside lung disease, almost everyone in this situation ends up on an acid-suppressing drug (a proton pump inhibitor, or PPI, like omeprazole or pantoprazole, or an H2 blocker like famotidine) usually for years, usually without anyone circling back to ask whether it’s still needed.[5]
The uncomfortable reality: in lung disease, acid suppression has a poor track record of actually helping the lungs. Carefully designed studies in asthma, COPD, and pulmonary fibrosis have generally failed to show the respiratory benefit people assume they’re getting.[6, 7, 8, 9, 13] And the most recent large studies are pointing the other way: long-term PPI use tracking with more breathing flare-ups, in a dose-dependent pattern, not fewer.[10, 14]
That makes sense once you realize what these drugs do and don’t do. They change how acidic the reflux is. They don’t stop the reflux from happening, they don’t fix the breathing mechanics that drive it, and by quieting stomach acid long-term they can weaken a frontline defense against the very kinds of infections that set lungs back.[3, 11]
None of This Would Have Surprised Traditional Chinese Medicine
TCM has never treated suppressing a bodily function, acid production included, as something to sustain indefinitely without consequence. The underlying principle is straightforward: quieting a process the body relies on, rather than correcting why that process is malfunctioning in the first place, tends to create new problems downstream even while it resolves the one in front of you. That’s not a philosophy specific to acid. It’s how TCM has approached long-term suppression of any kind.
What the newest cohort studies on PPIs are now documenting in hazard ratios and exacerbation curves is the same caution built into that framework generations ago. The tools are different. The warning underneath them is not.
Where Acid Suppression Earns Its Place
None of this makes these drugs the enemy, and the field has made real progress with them. For someone with Barrett’s esophagus (where years of acid injury can slowly nudge the esophageal lining toward cancer), daily acid suppression is one of the few tools shown to lower the risk of that progression, and that’s a risk worth taking seriously.[15, 16] Acid suppression also reliably heals the raw, eroded esophagus of severe esophagitis and controls genuinely acid-driven symptoms.[1] The problem was never that these medications exist. It’s that they get left running on autopilot in people who may no longer need them, with no one weighing what they’re doing downstream.[5]
Sequencing Matters as Much as Treating Both Systems
TCM treatment protocols take this principle a step further. In cases involving chronic lung dysfunction, certain complications are addressed before or alongside lung-directed care rather than after it, and acid reflux is frequently one of them. The reasoning is practical: poor digestion undermines nutrient absorption, and a body that isn’t absorbing well doesn’t have the raw material to repair lung tissue, no matter how targeted the lung treatment is.
In practice, this plays out consistently. Many patients report a substantial improvement in breathing and energy simply from getting reflux under control first, before any lung-specific or breath-training work even begins. Only then does the underlying chronic lung dysfunction get addressed directly, and often more effectively than it would have on its own.
This is another argument against treating any one system in isolation. Digestive function and lung function are addressed as connected in TCM because they are connected, a relationship the tradition has recognized for thousands of years and one that current research is only beginning to map. Get the sequencing right, treat both systems as a pair rather than as separate problems, and the results are additive rather than incremental.
Where Breath Actually Comes In
This is the intersection we care about most, because breath control is the foundation of everything we do. How you breathe (the pressure, the rhythm, the coordination between your diaphragm and the valve at the top of your stomach) is part of the very machinery that either invites reflux or keeps it down. Which raises an obvious and under-asked question: if disordered breathing helps drive reflux, could better breathing help settle it, without leaning harder on a drug that isn’t protecting the lungs anyway?
Coming Soon: Training the Breath (Part 3)
If breathing is part of the machinery connecting acid reflux and lung disease, the obvious next move is to train it. Part 3 gets practical: how diaphragmatic breath work targets the exact accommodation-and-sensitivity mechanics that drive reflux, why the diaphragm doubles as both a breathing muscle and part of the anti-reflux barrier wrapped around the top of the stomach, and how a breath-and-movement approach can work for the esophagus and the lungs at the same time. It’s also where some standard reflux advice and some natural lung-health strategies quietly collide, and we’ll show you how to think about it so you’re not fighting your own care plan.
Nothing here is a reason to stop a medication on your own. Some people genuinely need acid suppression, and stopping abruptly can backfire. The point is simpler: this deserves a real conversation, not autopilot.
References
- Fass R. Gastroesophageal Reflux Disease. New England Journal of Medicine. 2022.
- Chen JW, Vela MF, Peterson KA, Carlson DA. AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review. Clinical Gastroenterology and Hepatology. 2023.
- Vaezi MF, Yang YX, Howden CW. Complications of Proton Pump Inhibitor Therapy. Gastroenterology. 2017.
- Salvo EM, Ferko NC, Cash SB, Gonzalez A, Kahrilas PJ. Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors. Alimentary Pharmacology & Therapeutics. 2021.
- Targownik LE, Fisher DA, Saini SD. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review. Gastroenterology. 2022.
- Kopsaftis Z, Yap HS, Tin KS, Hnin K, Carson-Chahhoud KV. Pharmacological and Surgical Interventions for the Treatment of Gastro-Oesophageal Reflux in Adults and Children With Asthma. Cochrane Database of Systematic Reviews. 2021.
- Kikuchi S, Imai H, Tani Y, Tajiri T, Watanabe N. Proton Pump Inhibitors for Chronic Obstructive Pulmonary Disease. Cochrane Database of Systematic Reviews. 2020.
- Tran T, Assayag D, Ernst P, Suissa S. Effectiveness of Proton Pump Inhibitors in Idiopathic Pulmonary Fibrosis: A Population-Based Cohort Study. Chest. 2021.
- Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic Pulmonary Fibrosis (An Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine. 2022.
- Dehondt V, Van Vaerenbergh F, Verhamme K, Lahousse L. Exacerbation Risk by Chronic Proton Pump Inhibitor Use in Obstructive Lung Diseases. Chest. 2026.
- Zeng R, Ma Y, Zhang L, et al. Associations of Proton Pump Inhibitors With Susceptibility to Influenza, Pneumonia, and COVID-19: Evidence From a Large Population-Based Cohort Study. eLife. 2024.
- Bradley JA, Koop A, Lee AS, et al. Unravelling the Links Between Gastroesophageal Reflux and Lung Disease: New Insights. Digestive Diseases and Sciences. 2026.
- Yu F, Huang Q, Ye Y, Zhang L. Effectiveness of Proton-Pump Inhibitors in Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Controlled Trials. Frontiers in Medicine. 2022.
- Kang J, Lee R, Lee SW. Effects of Gastroesophageal Reflux Disease Treatment With Proton Pump Inhibitors on the Risk of Acute Exacerbation and Pneumonia in Patients With COPD. Respiratory Research. 2023.
- Wani S, Zhou MJ, Sawas T, et al. AGA Clinical Practice Guideline on Surveillance of Barrett’s Esophagus. Gastroenterology. 2025.
- Chen Y, Sun C, Wu Y, et al. Do Proton Pump Inhibitors Prevent Barrett’s Esophagus Progression to High-Grade Dysplasia and Esophageal Adenocarcinoma? An Updated Meta-Analysis. Journal of Cancer Research and Clinical Oncology. 2021.
Nutrition, Gut Health, and How Your Body Functions Are Deeply Connected
At Well Rooted Health, nutritional support is part of a whole-person approach rooted in how your spine and nervous system are functioning. Every new patient relationship begins with a comprehensive physical exam, in Westfield NJ, New York City, or virtually.
Request an Appointment
Call NJ: 908-588-7532 ยท NY: 212-655-5802 Email: info@gowellrooted.com